Richard Burr: “It is important that we examine the details of a national renewable portfolio standard.”

The FDA failed to do its job, plain and simple.

More than 278 therapies have been approved under the accelerated approval pathway over the 30 year history, saving and improving thousands of lives.

I urge my colleagues, don't make this mistake. I know there is great pressure to do Build Back Better. But this is not the right bill.

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.